Professional
Added to YB: 2025-07-03
Pitch date: 2025-06-30
RPTX [neutral]
Repare Therapeutics Inc.
+55.07%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States.
Market Cap
N/A
Pitch Price
$1.38
Price Target
2.00 (-7%)
Dividend
N/A
EV/EBITDA
N/A
P/E
N/A
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Clark Street Value Mid Year 2025 Portfolio Review: Current Position - Repare Therapeutics Inc.
RPTX (holding update): Busted biotech with $2/share liquidation value (possibly higher with IP). Slight positive: 10-Q confirms strategic review, stating 'We plan to explore a full range of strategic alternatives and partnerships across our portfolio to maximize shareholder value.'
Read full article (1 min)